According to a market report by Lucintel, the future of the global transcriptomics technologies market looks promising with opportunities in the drug discovery and diagnostics & disease profiling markets. The global transcriptomics technologies market is expected to reach an estimated $11.5 billion by 2030 from $7.3 billion in 2024,at a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are growing adoption of personalized medicines, increasing prevalence of chronic disorders, and on-going research and development in transciptomics.
A more than 150-page report to understand trends, opportunity and forecast in transcriptomics technologies market to 2030 by type (consumables, instruments, software, and services), technology (microarrays, q PCR, and sequencing technology), application (drug discovery, diagnostics & disease profiling, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the type category, consumables will remain a larger segment over the forecast period.
Within the application category, drug discovery is expected to remain the largest segment due to growing demand for new drugs to treat chronic diseases and rising application of transcriptomics technologies in drug discovery research.
Download sample by clicking on transcriptomics technologies market
In terms of region, North America will remain the largest region during the forecast period due to rising R&D investments by pharmaceutical and biotechnology companies in the region.
Agilent Technologies, Sequentia Biotech Sl, Affymetrix, LC Sciences, CD Genomics, Thermo Fisher Scientific, Life Technologies Corporation, Genxpro, Merck, Bio-Rad Laboratories are the major suppliers in the transcriptomics technologies market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected]To get access of more than 1000 reports at fraction of cost visit Lucintel'sAnalytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market &unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Sustainable Agriculture Market
ATM Outsourcing Service Market
Comments on “Lucintel Forecasts the Global Transcriptomics Technologies Market to Reach $11.5 billion by 2030”